FDA Drug Application (078688) for NADOLOL AND BENDROFLUMETHIAZIDE by MYLAN

Back to FDA Applications sponsored by MYLAN

Application Number078688
Product Number001
FormTABLET;ORAL
Dosage5MG;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNADOLOL AND BENDROFLUMETHIAZIDE
Active IngredientBENDROFLUMETHIAZIDE; NADOLOL

Active IngredientCount
List of drugs with Active Ingredient BENDROFLUMETHIAZIDE5
List of drugs with Active Ingredient NADOLOL4


Back to FDA Applications sponsored by MYLAN